Why the study?
Does an intravenous insulin infusion regimen improve glycaemic control in diabetic subjects following myocardial infarction?
Does an intravenous insulin infusion regimen improve glycaemic control in diabetic subjects following myocardial infarction?
Intravenous insulin infusion did not improve glycaemic control or clinical outcomes compared to routine control in diabetic patients following myocardial infarction.
IV insulin offers no glycaemic or mortality advantage over routine care post-MI in diabetics; leaves open optimal strategies pending RCTs.
Optimal metabolic control during the first twelve hours after myocardial infarction may be associated with improved survival in diabetic subjects. A comparison of an intravenous insulin infusion regimen aimed at improving blood glucose levels (n = 35), with 'routine control' (n = 34) in the post infarction period has been carried out in diabetic subjects admitted to four Coronary Care Units over a two year period. However, glycaemic control was similar in both groups (intravenous infusion regimen, mean +/- SD capillary blood glucose 10.3 +/- 2.1 mmol/l, 'routine control' glucose 10.7 +/- 3.6 mmol/l). There were no differences in the rates of arrhythmias (31% v 32%), heart failure (46% v 47%) or mortality (17% v 18%). Mortality in diabetic subjects was lower than that quoted in previous studies but was higher than in non-diabetic subjects admitted to the Coronary Care Unit during the same period. Attempts to improve glycaemic control by means of intravenous insulin infusion were unsuccessful.
No takes yet. Share an insight, caveat, or question.
Davies et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: